| Yunguang Liu, MD | |
|
390 E Longview St, Fayetteville, AR 72703-4618 | |
| (479) 442-0144 | |
| (479) 442-4557 |
| Full Name | Yunguang Liu |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 31 Years |
| Location | 390 E Longview St, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376860957 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | ME126407 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alta Bates Summit Medical Center | Oakland, CA | Hospital |
| Alta Bates Summit Medical Center - Alta Bates Camp | Berkeley, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alta East Bay Pathology, Inc. | 8224024013 | 8 |
News Archive
Case Western Reserve University School of Medicine and AstraZeneca, a global biopharmaceutical company, today announced the first patient enrolled in a Phase 2a trial to assess the effectiveness of AZD5847, a new test drug for patients with tuberculosis (TB), including patients with HIV co-infection.
Since vaping and e-cigarettes have become more popular over the last several years, many patients-;particularly during conversations about quitting smoking- have asked me, "Is vaping okay?" or "Is vaping safe?"
URL Pharma, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Colcrys(TM) (colchicine, USP) for the prophylaxis (prevention) of gout flares. Colcrys was first approved by the FDA on July 30, 2009 for the treatment of acute gout flares when taken at the first sign of a flare.
Eczema or atopic dermatitis is a skin condition that causes the skin to become itchy, red, and dry due to inflammation. Most commonly found in babies and children, previous recommendations say that daily moisturizer use is crucial in preventing eczema bouts.
In many pharmaceutical company and university laboratories, scientists are looking closely at kinase complexes because the enzymes play key roles in essential cell functions. By taking unusual steps to examine a kinase complex, researchers at Brown University and the National Institutes of Health have found a sought-after prize: an unprecedentedly detailed description of its structure complete with a rare location on its structure that could be a target for new therapeutic drugs.
› Verified 8 days ago
| Entity Name | Alta East Bay Pathology, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316909559 PECOS PAC ID: 8224024013 Enrollment ID: O20040426000754 |
News Archive
Case Western Reserve University School of Medicine and AstraZeneca, a global biopharmaceutical company, today announced the first patient enrolled in a Phase 2a trial to assess the effectiveness of AZD5847, a new test drug for patients with tuberculosis (TB), including patients with HIV co-infection.
Since vaping and e-cigarettes have become more popular over the last several years, many patients-;particularly during conversations about quitting smoking- have asked me, "Is vaping okay?" or "Is vaping safe?"
URL Pharma, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Colcrys(TM) (colchicine, USP) for the prophylaxis (prevention) of gout flares. Colcrys was first approved by the FDA on July 30, 2009 for the treatment of acute gout flares when taken at the first sign of a flare.
Eczema or atopic dermatitis is a skin condition that causes the skin to become itchy, red, and dry due to inflammation. Most commonly found in babies and children, previous recommendations say that daily moisturizer use is crucial in preventing eczema bouts.
In many pharmaceutical company and university laboratories, scientists are looking closely at kinase complexes because the enzymes play key roles in essential cell functions. By taking unusual steps to examine a kinase complex, researchers at Brown University and the National Institutes of Health have found a sought-after prize: an unprecedentedly detailed description of its structure complete with a rare location on its structure that could be a target for new therapeutic drugs.
› Verified 8 days ago
| Entity Name | Bass Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174253405 PECOS PAC ID: 9032111281 Enrollment ID: O20070201000181 |
News Archive
Case Western Reserve University School of Medicine and AstraZeneca, a global biopharmaceutical company, today announced the first patient enrolled in a Phase 2a trial to assess the effectiveness of AZD5847, a new test drug for patients with tuberculosis (TB), including patients with HIV co-infection.
Since vaping and e-cigarettes have become more popular over the last several years, many patients-;particularly during conversations about quitting smoking- have asked me, "Is vaping okay?" or "Is vaping safe?"
URL Pharma, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Colcrys(TM) (colchicine, USP) for the prophylaxis (prevention) of gout flares. Colcrys was first approved by the FDA on July 30, 2009 for the treatment of acute gout flares when taken at the first sign of a flare.
Eczema or atopic dermatitis is a skin condition that causes the skin to become itchy, red, and dry due to inflammation. Most commonly found in babies and children, previous recommendations say that daily moisturizer use is crucial in preventing eczema bouts.
In many pharmaceutical company and university laboratories, scientists are looking closely at kinase complexes because the enzymes play key roles in essential cell functions. By taking unusual steps to examine a kinase complex, researchers at Brown University and the National Institutes of Health have found a sought-after prize: an unprecedentedly detailed description of its structure complete with a rare location on its structure that could be a target for new therapeutic drugs.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yunguang Liu, MD 390 E Longview St, Fayetteville, AR 72703-4618 Ph: (479) 442-0144 | Yunguang Liu, MD 390 E Longview St, Fayetteville, AR 72703-4618 Ph: (479) 442-0144 |
News Archive
Case Western Reserve University School of Medicine and AstraZeneca, a global biopharmaceutical company, today announced the first patient enrolled in a Phase 2a trial to assess the effectiveness of AZD5847, a new test drug for patients with tuberculosis (TB), including patients with HIV co-infection.
Since vaping and e-cigarettes have become more popular over the last several years, many patients-;particularly during conversations about quitting smoking- have asked me, "Is vaping okay?" or "Is vaping safe?"
URL Pharma, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Colcrys(TM) (colchicine, USP) for the prophylaxis (prevention) of gout flares. Colcrys was first approved by the FDA on July 30, 2009 for the treatment of acute gout flares when taken at the first sign of a flare.
Eczema or atopic dermatitis is a skin condition that causes the skin to become itchy, red, and dry due to inflammation. Most commonly found in babies and children, previous recommendations say that daily moisturizer use is crucial in preventing eczema bouts.
In many pharmaceutical company and university laboratories, scientists are looking closely at kinase complexes because the enzymes play key roles in essential cell functions. By taking unusual steps to examine a kinase complex, researchers at Brown University and the National Institutes of Health have found a sought-after prize: an unprecedentedly detailed description of its structure complete with a rare location on its structure that could be a target for new therapeutic drugs.
› Verified 8 days ago
Dr. Paul R Hendrycy, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 Fax: 479-442-4557 | |
Dr. Bradley Dilday, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 Fax: 479-442-4557 | |
Jamie M Boone, D.O. Pathology Medicare: Medicare Enrolled Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 Fax: 479-442-4557 | |
Gregory Mckenzie, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 | |
Dr. Thomas J Simmons, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 Fax: 479-442-4557 | |
Dr. Saran Kraichoke, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 Fax: 479-442-4557 | |
Dr. Robert Morris Levy, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1100 N College Ave, P&lms (113), Fayetteville, AR 72703 Phone: 479-443-4301 |